Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targets

Cancer cell motility is a key driver of metastasis. Although the intravasation of cancer cells into the blood stream is highly dependent on their motility and metastatic dissemination is the primary cause of cancer related deaths, current therapeutic strategies do not target the genes and proteins t...

Full description

Bibliographic Details
Main Authors: Konstantin Stoletov, Lian Willetts, Perrin H. Beatty, John D. Lewis
Format: Article
Language:English
Published: Shared Science Publishers OG 2018-10-01
Series:Cell Stress
Subjects:
Online Access:http://www.cell-stress.com/researcharticles/intravital-imaging-tumor-screen-used-to-identify-novel-metastasis-blocking-therapeutic-targets/
_version_ 1818025846203482112
author Konstantin Stoletov
Lian Willetts
Perrin H. Beatty
John D. Lewis
author_facet Konstantin Stoletov
Lian Willetts
Perrin H. Beatty
John D. Lewis
author_sort Konstantin Stoletov
collection DOAJ
description Cancer cell motility is a key driver of metastasis. Although the intravasation of cancer cells into the blood stream is highly dependent on their motility and metastatic dissemination is the primary cause of cancer related deaths, current therapeutic strategies do not target the genes and proteins that are essential for cell motility. A primary reason for this is because the identification of cell motility-related genes that are relevant in vivo requires the visualization of metastatic lesions forming in an appropriate in vivo model. The cancer research community has lacked an in vivo and intravital metastatic cancer model that could be imaged as motility developed, in real-time. To address this, we developed a novel quantitative in vivo screening platform based on intravital imaging in shell-less ex ovo chick embryos. We applied this imaging approach to screen a human genome-wide short hairpin RNA library (shRNA) versus the highly motile head and neck cancer cells (HEp3 cell line) introduced into the chorioallantoic membrane (CAM) of chick embryos and identified multiple novel in vivo cancer cell motility-associated genes. When the expression of several of the identified genes was inhibited in the HEp3 tumors, we observed a nearly total block of spontaneous cancer metastasis.
first_indexed 2024-12-10T04:22:36Z
format Article
id doaj.art-ef2ad0988ea74504ba6fa5a2c0313cfe
institution Directory Open Access Journal
issn 2523-0204
language English
last_indexed 2024-12-10T04:22:36Z
publishDate 2018-10-01
publisher Shared Science Publishers OG
record_format Article
series Cell Stress
spelling doaj.art-ef2ad0988ea74504ba6fa5a2c0313cfe2022-12-22T02:02:22ZengShared Science Publishers OGCell Stress2523-02042018-10-0121027527810.15698/cst2018.10.159Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targetsKonstantin Stoletov0Lian Willetts1Perrin H. Beatty2John D. Lewis3Department of Oncology, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1.Department of Oncology, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1.Department of Oncology, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1.Department of Oncology, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1.Cancer cell motility is a key driver of metastasis. Although the intravasation of cancer cells into the blood stream is highly dependent on their motility and metastatic dissemination is the primary cause of cancer related deaths, current therapeutic strategies do not target the genes and proteins that are essential for cell motility. A primary reason for this is because the identification of cell motility-related genes that are relevant in vivo requires the visualization of metastatic lesions forming in an appropriate in vivo model. The cancer research community has lacked an in vivo and intravital metastatic cancer model that could be imaged as motility developed, in real-time. To address this, we developed a novel quantitative in vivo screening platform based on intravital imaging in shell-less ex ovo chick embryos. We applied this imaging approach to screen a human genome-wide short hairpin RNA library (shRNA) versus the highly motile head and neck cancer cells (HEp3 cell line) introduced into the chorioallantoic membrane (CAM) of chick embryos and identified multiple novel in vivo cancer cell motility-associated genes. When the expression of several of the identified genes was inhibited in the HEp3 tumors, we observed a nearly total block of spontaneous cancer metastasis.http://www.cell-stress.com/researcharticles/intravital-imaging-tumor-screen-used-to-identify-novel-metastasis-blocking-therapeutic-targets/ex ovo chick embryo modelfluorescence time-lapse intravital imaginghigh throughput sequencingintravasationmetastatic cancershRNA librarytherapeutic targets
spellingShingle Konstantin Stoletov
Lian Willetts
Perrin H. Beatty
John D. Lewis
Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targets
Cell Stress
ex ovo chick embryo model
fluorescence time-lapse intravital imaging
high throughput sequencing
intravasation
metastatic cancer
shRNA library
therapeutic targets
title Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targets
title_full Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targets
title_fullStr Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targets
title_full_unstemmed Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targets
title_short Intravital imaging tumor screen used to identify novel metastasis-blocking therapeutic targets
title_sort intravital imaging tumor screen used to identify novel metastasis blocking therapeutic targets
topic ex ovo chick embryo model
fluorescence time-lapse intravital imaging
high throughput sequencing
intravasation
metastatic cancer
shRNA library
therapeutic targets
url http://www.cell-stress.com/researcharticles/intravital-imaging-tumor-screen-used-to-identify-novel-metastasis-blocking-therapeutic-targets/
work_keys_str_mv AT konstantinstoletov intravitalimagingtumorscreenusedtoidentifynovelmetastasisblockingtherapeutictargets
AT lianwilletts intravitalimagingtumorscreenusedtoidentifynovelmetastasisblockingtherapeutictargets
AT perrinhbeatty intravitalimagingtumorscreenusedtoidentifynovelmetastasisblockingtherapeutictargets
AT johndlewis intravitalimagingtumorscreenusedtoidentifynovelmetastasisblockingtherapeutictargets